The European Parliament's ENVI committee session on December 3, 2025, featured a sharp clash over the potential classification of ethanol as a carcinogen and reproductive toxicant. The main divide was between MEPs advocating for a stringent, hazard-focused approach—primarily from the Greens/EFA—versus those urging a nuanced, exposure-route-based assessment including socioeconomic factors, notably members from the EPP, ECR, and Renew groups.
MEPs such as Andrea Wechsler (EPP), Tiemo Wölken (S&D), Alexandr Vondra (ECR), and Andreas Glück (Renew) argued forcefully that ethanol's risks should be evaluated based on actual dermal and inhalation exposure typical of disinfectant use, not oral ingestion data linked to drinking alcohol. They warned that ignoring this distinction could cause unnecessary alarm and economic harm. Conversely, Rasmus Nordqvist (Greens/EFA) and Christophe Clergeau (S&D) defended a pure hazard-based classification process under the EU's Classification, Labelling and Packaging Regulation (CLP), emphasizing legal rigor and warning against premature interference by socioeconomic considerations.
This debate unfolded in the ENVI committee meeting on December 3, 2025, where the European Commission representatives from DG SANTE and DG ENV outlined separate independent regulatory mechanisms: the Biocidal Products Regulation (BPR) evaluating ethanol's use as a disinfectant, and the CLP process potentially harmonizing carcinogen classification, with Greece planning a dossier submission by December 2026.
EPP and ECR MEPs presented detailed appeals for regulatory impact assessments that include real-world exposure data, effects on healthcare and cosmetics industries, risks to jobs, and supply chain vulnerabilities. They also called for harmonization between BPR and CLP regulations to prevent disproportionate restrictions and to avoid disruptions witnessed during the COVID-19 crisis. The Renew group highlighted ethanol’s critical role in healthcare infection prevention, underscoring that alternatives are often more toxic.
In contrast, Greens/EFA MEPs advocated adherence to the current hazard-based legal framework without dilution by socioeconomic concerns at the classification stage, maintaining that risk management should occur separately after classification. This camp warned of industry pressures attempting to weaken scientific procedures.
For EU regulatory bodies, the debate underscores the challenge of balancing scientific assessment with socioeconomic realities. National authorities are poised to rely on Greece's dossier and further data gathering before decisions. Healthcare sectors risk losing a vital disinfectant if classification becomes overly restrictive, affecting patient safety. The cosmetics and manufacturing sectors warn of competitiveness losses due to potential supply disruptions and stricter regulation. Consumers could face confusion and unfounded fears if classification conflates oral ingestion risks with disinfectant exposure.
The Commission committed to completing the BPR evaluation with integrated assessment of exposure routes and socioeconomic impacts, while CLP actions await Greece’s dossier and subsequent scientific scrutiny. The debate signals further robust consultations and impact analyses before any legislative proposals, reflecting the complexity of balancing harm prevention with economic and public health safeguards.